Literature DB >> 21037099

Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells.

Luke Barron1, Hans Dooms, Katrina K Hoyer, Wilson Kuswanto, Jerry Hofmann, William E O'Gorman, Abul K Abbas.   

Abstract

IL-2 controls the survival of regulatory T cells (Tregs), but it is unclear whether IL-2 also directly affects Treg suppressive capacity in vivo. We have found that eliminating Bim-dependent apoptosis in IL-2- and CD25-deficient mice restored Treg numbers but failed to cure their lethal autoimmune disease, demonstrating that IL-2-dependent survival and suppressive activity can be uncoupled in Tregs. Treatment with IL-2-anti-IL-2-Ab complexes enhanced the numbers and suppressive capacity of IL-2-deprived Tregs with striking increases in CD25, CTLA-4, and CD39/CD73 expression. Although cytokine treatment induced these suppressive mechanisms in both IL-2(-/-) and IL-2(-/-)Bim(-/-) mice, it only reversed autoimmune disease in the latter. Our results suggest that successful IL-2 therapy of established autoimmune diseases will require a threshold quantity of Tregs present at the start of treatment and show that the suppressive capacity of Tregs critically depends on IL-2 even when Treg survival is independent of this cytokine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037099      PMCID: PMC3059533          DOI: 10.4049/jimmunol.0903940

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  The role of BH3-only proteins in the immune system.

Authors:  Andreas Strasser
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

2.  CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.

Authors:  Pushpa Pandiyan; Lixin Zheng; Satoru Ishihara; Jennifer Reed; Michael J Lenardo
Journal:  Nat Immunol       Date:  2007-11-04       Impact factor: 25.606

Review 3.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2008-03       Impact factor: 25.606

4.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

5.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

6.  T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine.

Authors:  James J Kobie; Pranav R Shah; Li Yang; Jonathan A Rebhahn; Deborah J Fowell; Tim R Mosmann
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

7.  Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Authors:  Onur Boyman; Marek Kovar; Mark P Rubinstein; Charles D Surh; Jonathan Sprent
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

8.  Targeting T cell-specific costimulators and growth factors in a model of autoimmune hemolytic anemia.

Authors:  Katrina K Hoyer; Kristen Wolslegel; Hans Dooms; Abul K Abbas
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

9.  A two-step process for thymic regulatory T cell development.

Authors:  Chan-Wang Joaquim Lio; Chyi-Song Hsieh
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

10.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Authors:  Silvia Deaglio; Karen M Dwyer; Wenda Gao; David Friedman; Anny Usheva; Anna Erat; Jiang-Fan Chen; Keiichii Enjyoji; Joel Linden; Mohamed Oukka; Vijay K Kuchroo; Terry B Strom; Simon C Robson
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

View more
  102 in total

1.  Spontaneous autoimmunity in the absence of IL-2 is driven by uncontrolled dendritic cells.

Authors:  Sara H Isakson; Shoshana D Katzman; Katrina K Hoyer
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.

Authors:  Grégory Ehx; Gilles Fransolet; Laurence de Leval; Stéphanie D'Hondt; Sophie Lucas; Muriel Hannon; Loïc Delens; Sophie Dubois; Pierre Drion; Yves Beguin; Stéphanie Humblet-Baron; Frédéric Baron
Journal:  Oncoimmunology       Date:  2017-04-12       Impact factor: 8.110

3.  Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.

Authors:  Jennifer S Whangbo; Haesook T Kim; Sarah Nikiforow; John Koreth; Ana C Alho; Bryn Falahee; Soomin Kim; Katharine Dusenbury; Marie J Fields; Carol G Reynolds; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood Adv       Date:  2019-04-09

4.  IL-2/anti-IL-2 complex: a novel strategy of in vivo regulatory T cell expansion in renal injury.

Authors:  Yuan Min Wang; Stephen I Alexander
Journal:  J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 10.121

5.  CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.

Authors:  Ekua W Brenu; Timothy J Bartley; Casey M Wright; Emma E Hamilton-Williams
Journal:  Immunol Cell Biol       Date:  2017-06-14       Impact factor: 5.126

Review 6.  Role of Metabolism in the Immunobiology of Regulatory T Cells.

Authors:  Mario Galgani; Veronica De Rosa; Antonio La Cava; Giuseppe Matarese
Journal:  J Immunol       Date:  2016-10-01       Impact factor: 5.422

7.  PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.

Authors:  Takeru Asano; Yusuke Meguri; Takanori Yoshioka; Yuriko Kishi; Miki Iwamoto; Makoto Nakamura; Yasuhisa Sando; Hideo Yagita; John Koreth; Haesook T Kim; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Yoshinobu Maeda; Mitsune Tanimoto; Jerome Ritz; Ken-Ichi Matsuoka
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

8.  Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out mice.

Authors:  Y M Wang; G Y Zhang; Y Wang; M Hu; J J Zhou; A Sawyer; Q Cao; Y Wang; G Zheng; V W S Lee; D C H Harris; S I Alexander
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

9.  The phenotype and activation status of regulatory T cells during Friend retrovirus infection.

Authors:  Jara J Joedicke; Kirsten K Dietze; Gennadiy Zelinskyy; Ulf Dittmer
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

Review 10.  MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function.

Authors:  Li Zhou; Jang-June Park; Quanhui Zheng; Zheng Dong; Qingsheng Mi
Journal:  Cell Mol Immunol       Date:  2011-08-08       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.